KYMR
Kymera Therapeutics, Inc.
Stock
$107.39−2.73 (−2.48%)Close Oct 2, 2026
- Revenue, 2025
- $39M
- YoY, 2025
- −16.7%
- 5-year CAGR
- +2.9%
Revenue
Revenue by fiscal year
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $39M | −16.7% |
| 2024 | $47M | −40.1% |
| 2023 | $79M | +67.8% |
| 2022 | $47M | −35.7% |
| 2021 | $73M | +114.0% |
| 2020 | $34M | +1,060.0% |
| 2019 | $2.9M | — |